www.me-med.com
Open in
urlscan Pro
35.242.251.130
Public Scan
Submitted URL: http://me-med.com/
Effective URL: https://www.me-med.com/
Submission: On April 26 via manual from US — Scanned from DE
Effective URL: https://www.me-med.com/
Submission: On April 26 via manual from US — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
Skip to Main Content NO. OF UNNECESSARY ANTIBIOTIC PRESCRIPTIONS NO. OF UNNECESSARY ANTIBIOTIC PRESCRIPTIONS * Company * Overview * Team * Awards * Careers * Contact Us * What's New * Products * MeMed BV * MeMed Key * MeMed COVID-19 Severity * Pipeline * Evidence * Publications & Conferences * Support * Document Library * Instructional Videos Key 1.1 * Instructional Videos Key 1.2 * Instructional Videos COVID-19 Severity * Customer Support * AMR * The crisis of antibiotic misuse * Facts & Figures * The Resistant Bacteria Problem * The Diagnostic Gap * The Economic Impact * More Use tab to navigate through the menu items. TO TREAT OR NOT TO TREAT? MILLIONS OF DECISIONS A DAY. LET'S MAKE THEM BETTER. MeMed Mission Translating the complex signaling of the immune system into simple diagnostic insights. MeMed BV® The only test for distinguishing between bacterial and viral infections that is both double-blind and externally validated. MeMed Key® A pioneering point-of-need immunoassay platform to deliver results within minutes. WHERE HOST IMMUNE RESPONSE MEETS MACHINE LEARNING DIAGNOSTICS WE ARE APPLYING MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE TO THE COMPLEX SIGNALING OF THE WORLD'S MOST ACCURATE DIAGNOSTIC SYSTEM, THE IMMUNE SYSTEM. OUR AI-BASED DIAGNOSTICS ADDRESS KEY CLINICAL AND MEDICAL CHALLENGES IN INFECTIOUS DISEASES AND INFLAMMATORY DISORDERS. THE TEST: MEMED BV MEMED BV IS A PIONEERING TEST FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS THAT RELIES ON THE MOST ACCURATE DETECTION SYSTEM - THE BODY'S IMMUNE SYSTEM. MEMED BV AIMS TO SUPPORT PHYSICIANS IN MAKING BETTER INFORMED ANTIBIOTIC TREATMENT DECISIONS AND TACKLING ANTIMICROBIAL RESISTANCE - ONE OF THE BIGGEST HEALTHCARE CHALLENGES OF OUR TIME. THE PLATFORM: MEMED KEY MEMED KEY IS A FIRST OF ITS KIND IMMUNOASSAY PLATFORM, THAT OPENS THE WAY TO MEASURING MULTIPLE PROTEINS WITH CENTRAL LAB PERFORMANCE AT THE POINT-OF-NEED. KEY WILL DELIVER MEMED BV TEST RESULTS IN 15 MINUTES. FULL STORY THE EVIDENCE: PUBLISHED CLINICAL DATA OUR TECHNOLOGY AND PRODUCTS HAVE BEEN DEVELOPED AND RIGOROUSLY VALIDATED IN LARGE MULTINATIONAL CLINICAL STUDIES ENCOMPASSING THOUSANDS OF PATIENTS AND PUBLISHED IN HIGH IMPACT SCIENTIFIC AND MEDICAL JOURNALS. WHAT'S NEW RAPID TEST TO DISTINGUISH BACTERIAL AND VIRAL INFECTIONS WINS US APPROVAL COVID-19 SEVERITY TEST IS APPROVED FOR SALE IN THE UK PIONEERING TEST WHICH CAN INDICATE COVID-19 SEVERITY RECEIVES CE MARK MEMED’S DIAGNOSTICS, BV TEST AND KEY PLATFORM GET 510(K) CLEARANCE JOURNAL OF INFECTION: A SYSTEMATIC REVIEW OF HOST BIOMARKERS MEMED’S DIAGNOSTICS, BV TEST AND KEY PLATFORM GET 510(K) CLEARANCE MEMED CO-FOUNDER & CEO, DR. ERAN EDEN PRESENTED AT ECCMID 2021, WITH HIGHLIGHTS FROM THE OBSERVER STUDY “A HOST ASSAY COMPRISING TRAIL, IP-10 AND CRP CAN IMPROVE ANTIBIOTIC TREATMENT DECISIONS FOR VIRAL PCR POSITIVE ADULTS BY ACCURATELY RULING OUT CO-INFECTION” VIEW HERE Learn More We're growing! If you are a top tier professional and a team player we would be happy to hear from you. Check out our current open positions. * Company * Overview * Team * Awards * Careers * Contact Us * What's New * Products * MeMed BV * MeMed Key * MeMed COVID-19 Severity * Pipeline * Evidence * Publications & Conferences * Support * Document Library * Instructional Videos Key 1.1 * Instructional Videos Key 1.2 * Instructional Videos COVID-19 Severity * Customer Support * AMR * The crisis of antibiotic misuse * Facts & Figures * The Resistant Bacteria Problem * The Diagnostic Gap * The Economic Impact * More Use tab to navigate through the menu items. * * * * ©MEMED 2022 ALL RIGHTS RESERVED | PRIVACY POLICY | TERMS OF USE WEBINAR Differentiating Viral from Bacterial Infections with MeMed BV: Clinical Best Practices, Case Studies & Insights Dr. Adi Klein, Chief of Pediatrics at Hillel Yaffe Medical Center April 28, 2022 | 1:00pm EDT Register Now Миссия MeMed Diagnostics - преобразовать сложные сигналы иммунной системы в простые диагностические данные, которые изменят наши методы лечения инфекционных и воспалительных заболеваний - в нужном месте и в нужное время.